Dean Y. Li
Director · RECURSION PHARMACEUTICALS, INC.
IndividualSelling only
- 2024
- Oct 2, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dean Y. Li files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Blake Borgeson - $3.38M in RXRX purchases and sales in the last 12 months
- Christopher Gibson - $2.41M in RXRX purchases and sales in the last 12 months
- Najat Khan - $258K in RXRX purchases and sales in the last 12 months
- Robert Hershberg - $125K in RXRX purchases and sales in the last 12 months
- Ben R. Taylor - $68K in RXRX purchases and sales in the last 12 months
- Namandje Bumpus - $28K in RXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dean Y. Li?
Dean Y. Li is a corporate insider, tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dean Y. Li submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Dean Y. Li been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($2.99M) across all tracked filings.
